PL2813502T3 - Antagonisty receptora bradykininy i zawierające je kompozycje - Google Patents
Antagonisty receptora bradykininy i zawierające je kompozycjeInfo
- Publication number
- PL2813502T3 PL2813502T3 PL13172137T PL13172137T PL2813502T3 PL 2813502 T3 PL2813502 T3 PL 2813502T3 PL 13172137 T PL13172137 T PL 13172137T PL 13172137 T PL13172137 T PL 13172137T PL 2813502 T3 PL2813502 T3 PL 2813502T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- receptor antagonists
- bradykinin receptor
- bradykinin
- Prior art date
Links
- 229940122155 Bradykinin receptor antagonist Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13172137.5A EP2813502B1 (en) | 2013-06-14 | 2013-06-14 | Bradykinin receptor antagonists and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2813502T3 true PL2813502T3 (pl) | 2017-06-30 |
Family
ID=48607169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13172137T PL2813502T3 (pl) | 2013-06-14 | 2013-06-14 | Antagonisty receptora bradykininy i zawierające je kompozycje |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9409876B2 (pl) |
| EP (1) | EP2813502B1 (pl) |
| CY (1) | CY1118778T1 (pl) |
| DK (1) | DK2813502T3 (pl) |
| ES (1) | ES2621085T3 (pl) |
| HR (1) | HRP20170455T1 (pl) |
| HU (1) | HUE032179T2 (pl) |
| LT (1) | LT2813502T (pl) |
| ME (1) | ME02580B (pl) |
| PL (1) | PL2813502T3 (pl) |
| PT (1) | PT2813502T (pl) |
| RS (1) | RS55977B1 (pl) |
| SI (1) | SI2813502T1 (pl) |
| SM (1) | SMT201700161T1 (pl) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996006083A1 (en) | 1994-08-24 | 1996-02-29 | Pfizer Pharmaceuticals Inc. | 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists |
| FR2743562B1 (fr) * | 1996-01-11 | 1998-04-03 | Sanofi Sa | Derives de n-(arylsulfonyl) aminoacides, leur preparation, les compositions pharmaceutiques en contenant |
| DE60005355T2 (de) * | 1999-07-15 | 2004-07-01 | Pharmacopeia, Inc. | Bradikinin b1 rezeptor antagonisten |
| WO2002092556A1 (en) * | 2001-05-14 | 2002-11-21 | Novartis Ag | Sulfonamide derivatives |
| AU2002346048A1 (en) | 2001-06-07 | 2002-12-16 | Merck And Co., Inc. | Benzodiazepine bradykinin antagonists |
| DE10134721A1 (de) | 2001-07-17 | 2003-02-06 | Bayer Ag | Tetrahydrochinoxaline |
| US7183281B2 (en) | 2002-05-03 | 2007-02-27 | Elan Pharmaceuticals, Inc. | Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| FR2840897B1 (fr) * | 2002-06-14 | 2004-09-10 | Fournier Lab Sa | Nouveaux derives d'arylsulfonamides et leur utilisation en therapeutique |
| US20040034064A1 (en) | 2002-08-06 | 2004-02-19 | Kuduk Scott D. | 2-(biarylalkyl)amino-3-(alkanoylamino)pyridine derivatives |
| US20040063761A1 (en) | 2002-08-06 | 2004-04-01 | Kuduk Scott D. | 2-(biarylalkyl)amino-3-(fluoroalkanoylamino)pyridine derivatives |
| US20040029920A1 (en) | 2002-08-06 | 2004-02-12 | Kuduk Scott D. | 2-(biarylalkyl)amino-3-(heterocyclylcarbonylamino)-pyridine derivatives |
| US6908921B2 (en) | 2002-12-13 | 2005-06-21 | Merck & Co., Inc. | Quinoxalinone derivatives as bradykinin B1 antagonists |
| US20060173023A1 (en) * | 2005-02-01 | 2006-08-03 | Wood Michael R | 2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation |
| TW201024279A (en) | 2008-09-18 | 2010-07-01 | Jerini Ag | Use of B1 receptor antagonists |
-
2013
- 2013-06-14 SM SM20170161T patent/SMT201700161T1/it unknown
- 2013-06-14 PL PL13172137T patent/PL2813502T3/pl unknown
- 2013-06-14 PT PT131721375T patent/PT2813502T/pt unknown
- 2013-06-14 RS RS20170336A patent/RS55977B1/sr unknown
- 2013-06-14 EP EP13172137.5A patent/EP2813502B1/en active Active
- 2013-06-14 DK DK13172137.5T patent/DK2813502T3/en active
- 2013-06-14 HU HUE13172137A patent/HUE032179T2/hu unknown
- 2013-06-14 LT LTEP13172137.5T patent/LT2813502T/lt unknown
- 2013-06-14 ME MEP-2017-23A patent/ME02580B/me unknown
- 2013-06-14 ES ES13172137.5T patent/ES2621085T3/es active Active
- 2013-06-14 SI SI201330529A patent/SI2813502T1/sl unknown
-
2014
- 2014-06-13 US US14/304,577 patent/US9409876B2/en active Active
-
2017
- 2017-03-20 HR HRP20170455TT patent/HRP20170455T1/hr unknown
- 2017-03-29 CY CY20171100386T patent/CY1118778T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20170455T1 (hr) | 2017-06-02 |
| US20140371274A1 (en) | 2014-12-18 |
| HUE032179T2 (hu) | 2017-09-28 |
| ES2621085T3 (es) | 2017-06-30 |
| RS55977B1 (sr) | 2017-09-29 |
| EP2813502A1 (en) | 2014-12-17 |
| PT2813502T (pt) | 2017-04-06 |
| US9409876B2 (en) | 2016-08-09 |
| CY1118778T1 (el) | 2017-07-12 |
| EP2813502B1 (en) | 2017-01-04 |
| LT2813502T (lt) | 2017-03-10 |
| ME02580B (me) | 2017-06-20 |
| DK2813502T3 (en) | 2017-02-27 |
| SI2813502T1 (sl) | 2017-05-31 |
| SMT201700161T1 (it) | 2017-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285390A (en) | Arylquinazolines, their preparation and pharmaceutical preparations containing them | |
| IL288961A (en) | Pharmaceutical preparations | |
| IL240290A0 (en) | History of pyridazinone-amide and pharmaceutical preparations containing them | |
| SMT201900684T1 (it) | Composizione farmaceutica combinata | |
| PL2943181T3 (pl) | Kompozycje farmaceutyczne | |
| IL246377A0 (en) | Pharmaceutical preparations for oral administration | |
| ZA201408333B (en) | Pharmaceutical compositions | |
| PL3043778T3 (pl) | Kompozycje farmaceutyczne zawierające refametinib | |
| IL240292B (en) | History of quinazoline and pharmaceutical preparations containing them | |
| IL240875B (en) | Heterocyclic compounds and pharmaceutical preparations containing them | |
| TWI562776B (en) | Pharmaceutical composition and uses thereof | |
| SG11201601477VA (en) | Pharmaceutical composition | |
| ZA201506637B (en) | Micronized pharmaceutical compositions | |
| HUP1300496A2 (hu) | Stabil kombinációs gyógyszerkészítmény | |
| ZA201601645B (en) | Bendamustine pharmaceutical compositions | |
| IL244365A0 (en) | pharmaceutical preparation | |
| SG11201509114TA (en) | Pharmaceutical compositions | |
| PT2813502T (pt) | Antagonistas do recetor da bradicinina e composições farmacêuticas que os contêm | |
| GB201304699D0 (en) | Pharmaceutical compositions | |
| HUE047749T2 (hu) | Gyógyszereket alacsony dózisban tartalmazó gyógyászati készítmények | |
| GB201321497D0 (en) | Pharmaceutical compositions | |
| GB201312851D0 (en) | Pharmaceutical compositions | |
| ZA201300163B (en) | Improved pharmaceutical composition containing an aldosterone antagonist and method for the preparation thereof | |
| GB201304625D0 (en) | New pharmaceutical composition |